10x Genomics (TXG) Cash from Investing Activities Growth (3y) (2021 - 2026)
10x Genomics (TXG) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | -9.34% |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 255.16% |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | -15.03% |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | -26.22% |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 131.77% |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 89.85% |
| 10 | Omnicell | 1.89 Bn | 1.65 Bn | 140.36 Mn | -5.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.22% |
| Dec 31, 2025 | 62.11% |
| Sep 30, 2025 | 35.39% |
| Jun 30, 2025 | 67.57% |
| Mar 31, 2025 | 80.56% |
| Dec 31, 2024 | -23.16% |
| Sep 30, 2024 | 43.66% |
| Jun 30, 2024 | 41.28% |
| Mar 31, 2024 | 30.84% |
| Dec 31, 2023 | 37.30% |
| Sep 30, 2023 | 79.05% |
| Jun 30, 2023 | 12.84% |
| Mar 31, 2023 | 156.36% |
| Dec 31, 2022 | -71.46% |
| Sep 30, 2022 | -33.62% |
| Jun 30, 2022 | -27.95% |
| Mar 31, 2022 | -201.83% |
| Dec 31, 2021 | -113.72% |